Related Experiment Video
Updated: Jul 6, 2026
06:03
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
[Mechanisms in pulmonary fibrosis]
Bruno Crestani1, Sylvain Marchand-Adam, Aurélie Fabre
1Unité Inserm 700, faculté Xavier-Bichat, université Paris-7, et service de pneumologie A, hôpital Bichat, 75018 Paris. bruno.crestani@bch.aphp.fr
La Revue Du Praticien
|March 7, 2008
Summary
Idiopathic pulmonary fibrosis (IPF) involves lung destruction from repeated alveolar epithelial cell injury, not primarily inflammation. This injury activates mesenchymal cells, leading to fibroblast accumulation and irreversible lung damage.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Pathology
Context:
- Idiopathic pulmonary fibrosis (IPF) remains a significant clinical challenge with poorly understood pathogenesis.
- While inflammation's role is debated, recent focus is on epithelial cell injury.
- Understanding the cellular and molecular drivers of lung fibrosis is crucial for therapeutic development.
Purpose:
- To elucidate the biological mechanisms driving idiopathic pulmonary fibrosis (IPF).
- To investigate the role of alveolar epithelial cell apoptosis and subsequent mesenchymal cell activation in lung fibrosis.
- To explore potential sources of fibroblast accumulation in the fibrotic lung.
Summary:
- Excessive apoptosis of alveolar epithelial cells suggests IPF results from repeated epithelial cell injury.
- Activated epithelial cells promote mesenchymal cell recruitment, proliferation, and activation, forming fibroblastic foci.
- Fibroblast accumulation in IPF may involve fibrocytes and transdifferentiation of epithelial, endothelial, and mesothelial cells.
Impact:
- This research provides insights into the cellular basis of IPF, potentially identifying new therapeutic targets.
- Clarifying the mechanisms of fibroblast accumulation could lead to strategies to halt or reverse lung fibrosis.
- Advances in understanding IPF pathogenesis may improve diagnostic and prognostic capabilities.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...